Fig. 2From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysisClinical courses of each of the six patients who had pneumothorax episodes during pazopanib treatmentBack to article page